{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:41:10Z","timestamp":1793313670460,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Health Popul Nutr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To characterize global temporal trends in the incidence of polycystic ovary syndrome (PCOS) from 1990 to 2021 by applying an age\u2013period\u2013cohort (APC) analytical framework across 204 countries and territories, and to assess how these incidence patterns vary according to socio-demographic context.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study analyzed PCOS incidence trends from 1990 to 2021 across 204 countries using an APC analysis. Data were sourced from the Global Burden of Disease Study 2021, focusing on crude and age-standardized incidence rates, disaggregated by region and socio-demographic index (SDI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The global incidence of PCOS increased from 1.48\u00a0million cases in 1990 to 2.3\u00a0million in 2021. The age-standardized incidence rate in 2021 was 63.26 per 100,000 population (95% CI: 45.41 to 87.28). High SDI regions recorded the highest incidence rates, with a rate of 90.13 per 100,000 (95% CI: 66.94 to 122.36). In contrast, low SDI regions had the lowest incidence rates at 36.8 per 100,000 (95% CI: 25.83 to 52.19). The APC model revealed a global net drift of 0.18 (95% CI: -0.02 to 0.37), with significant age and period effects, particularly among younger age groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This APC analysis reveals marked increases in global PCOS incidence driven by adolescent age groups, mid-2000s period effects, and recent birth cohorts. Findings underscore the need for age- and cohort-targeted interventions and harmonized diagnostics to address the growing PCOS burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41043-025-01002-1","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T08:21:59Z","timestamp":1751962919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Global trends in polycystic ovarian syndrome over 30 years: an age-period-cohort study of 204 countries and territories (1990\u20132021)"],"prefix":"10.1186","volume":"44","author":[{"given":"Lanxiang","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baozhu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"1002_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz R, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:1\u201318.","journal-title":"Nat Rev Dis Primers"},{"key":"1002_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","volume":"86","author":"P Anagnostis","year":"2018","unstructured":"Anagnostis P, Tarlatzis BC, Kauffman RP. Polycystic ovarian syndrome (PCOS): long-term metabolic consequences. Metabolism - Clin Experimental. 2018;86:33\u201343.","journal-title":"Metabolism - Clin Experimental"},{"key":"1002_CR3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","volume":"405","author":"Global","year":"2025","unstructured":"GBD 2021 Adult BMI Collaborators. Global, regional, and national prevalence of adult overweight and obesity, 1990\u20132021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet. 2025;405:813\u201338.","journal-title":"Lancet"},{"key":"1002_CR4","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","volume":"404","author":"Worldwide trends in diabetes","year":"2024","unstructured":"Worldwide trends in diabetes. Prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024;404:2077\u201393.","journal-title":"Lancet"},{"key":"1002_CR5","doi-asserted-by":"publisher","first-page":"103043","DOI":"10.1016\/j.arcmed.2024.103043","volume":"55","author":"Global Prevalence of Nonalcoholic Fatty Liver Disease","year":"2024","unstructured":"Global Prevalence of Nonalcoholic Fatty Liver Disease. An updated review meta-analysis comprising a population of 78 million from 38 countries. Arch Med Res. 2024;55:103043.","journal-title":"Arch Med Res"},{"key":"1002_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/cen.14421","volume":"95","author":"TM Barber","year":"2021","unstructured":"Barber TM, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol. 2021;95:531\u201341.","journal-title":"Clin Endocrinol"},{"key":"1002_CR7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.fertnstert.2019.06.016","volume":"112","author":"BY Jarrett","year":"2019","unstructured":"Jarrett BY, et al. Impact of right\u2013left differences in ovarian morphology on the ultrasound diagnosis of polycystic ovary syndrome. Fertil Steril. 2019;112:939\u201346.","journal-title":"Fertil Steril"},{"key":"1002_CR8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/humupd\/dmg044","volume":"9","author":"AH Balen","year":"2003","unstructured":"Balen AH, Laven JSE, Tan S-L, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update. 2003;9:505\u201314.","journal-title":"Hum Reprod Update"},{"key":"1002_CR9","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1093\/humrep\/del161","volume":"21","author":"P-M Lam","year":"2006","unstructured":"Lam P-M, Raine-Fenning N. The role of three-dimensional ultrasonography in polycystic ovary syndrome. Hum Reprod. 2006;21:2209\u201315.","journal-title":"Hum Reprod"},{"key":"1002_CR10","doi-asserted-by":"publisher","unstructured":"Panicker PH, Shah K, Karamchandani SCNN. Based image descriptor for polycystic ovarian morphology from transvaginal ultrasound. in 2023 International Conference on Communication System, Computing and IT Applications (CSCITA) 2023:148\u2013152. https:\/\/doi.org\/10.1109\/CSCITA55725.2023.10104931","DOI":"10.1109\/CSCITA55725.2023.10104931"},{"key":"1002_CR11","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/humupd\/dmy022","volume":"24","author":"MA Skiba","year":"2018","unstructured":"Skiba MA, Islam RM, Bell RJ, Davis SR. Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2018;24:694\u2013709.","journal-title":"Hum Reprod Update"},{"key":"1002_CR12","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31:2841\u201355.","journal-title":"Hum Reprod"},{"key":"1002_CR13","doi-asserted-by":"crossref","unstructured":"Long C et al. Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: a systematic review and meta-analysis. Front Endocrinol. 2022;13.","DOI":"10.3389\/fendo.2022.980405"},{"key":"1002_CR14","doi-asserted-by":"publisher","first-page":"8477","DOI":"10.1021\/am4019115","volume":"5","author":"S-H Wang","year":"2013","unstructured":"Wang S-H, Hou S-S, Kuo P-L, Teng H. Poly(ethylene oxide)-co-poly(propylene oxide)-based gel electrolyte with high ionic conductivity and mechanical integrity for lithium-ion batteries. ACS Appl Mater Interfaces. 2013;5:8477\u201385.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1002_CR15","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"AJ Ferrari","year":"2024","unstructured":"Ferrari AJ, et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2133\u201361.","journal-title":"Lancet"},{"key":"1002_CR16","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"M Naghavi","year":"2024","unstructured":"Naghavi M, et al. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2100\u201332.","journal-title":"Lancet"},{"key":"1002_CR17","doi-asserted-by":"publisher","unstructured":"Zheng P, Aravkin A, Barber R, Sorensen R, Murray C. Trimmed constrained mixed effects models: formulations and algorithms. 2020;2020.01.28.923599. Preprint at https:\/\/doi.org\/10.1101\/2020.01.28.923599","DOI":"10.1101\/2020.01.28.923599"},{"key":"1002_CR18","unstructured":"Polycystic ovarian syndrome - Level 4 cause | Institute for health metrics and evaluation. https:\/\/www.healthdata.org\/research-analysis\/diseases-injuries-risks\/factsheets\/2021-polycystic-ovarian-syndrome-level-4"},{"key":"1002_CR19","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1158\/1055-9965.EPI-14-0300","volume":"23","author":"PS Rosenberg","year":"2014","unstructured":"Rosenberg PS, Check DP, Anderson WF. A web tool for age\u2013period\u2013cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev. 2014;23:2296\u2013302.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1002_CR20","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1086\/587154","volume":"113","author":"Y Yang","year":"2008","unstructured":"Yang Y, Schulhofer-Wohl S, Fu WJ, Land KC. The intrinsic estimator for age\u2010period\u2010cohort analysis: what it is and how to use it. Am J Sociol. 2008;113:1697\u2013736.","journal-title":"Am J Sociol"},{"key":"1002_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/03014460.2019.1707872","volume":"47","author":"A Bell","year":"2020","unstructured":"Bell A. Age period cohort analysis: a review of what we should and shouldn\u2019t do. Ann Hum Biol. 2020;47:208\u201317.","journal-title":"Ann Hum Biol"},{"key":"1002_CR22","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1158\/1055-9965.EPI-11-0421","volume":"20","author":"PS Rosenberg","year":"2011","unstructured":"Rosenberg PS, Anderson WF. Age-period-cohort models in cancer surveillance research: ready for prime time?? Cancer Epidemiol Biomarkers Prev. 2011;20:1263\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1002_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/IJWH.S490836","volume":"17","author":"B Jiang","year":"2025","unstructured":"Jiang B. The global burden of polycystic ovary syndrome in women of reproductive age: findings from the GBD 2019 study. IJWH. 2025;17:153\u201365.","journal-title":"IJWH"},{"key":"1002_CR24","doi-asserted-by":"publisher","unstructured":"(PDF) Geographical prevalence of polycystic ovary syndrome as determined by region and race\/ethnicity. ResearchGate https:\/\/doi.org\/10.3390\/ijerph15112589","DOI":"10.3390\/ijerph15112589"},{"key":"1002_CR25","unstructured":"Global Nutrition Report | Country Nutrition Profiles - Global Nutrition Report. https:\/\/globalnutritionreport.org\/resources\/nutrition-profiles\/europe\/southern-europe\/italy\/?utm_source=chatgpt.com"},{"key":"1002_CR26","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.3390\/diagnostics12102555","volume":"12","author":"E Carmina","year":"2022","unstructured":"Carmina E. Need to introduce the finding of obesity or normal body weight in the current diagnostic criteria and in the classification of PCOS. Diagnostics (Basel). 2022;12:2555.","journal-title":"Diagnostics (Basel)"},{"key":"1002_CR27","first-page":"604","volume":"102","author":"M Gibson-Helm","year":"2017","unstructured":"Gibson-Helm M, Teede H, Dunaif A, Dokras A. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metabolism. 2017;102:604\u201312.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1002_CR28","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/S2213-8587(20)30269-2","volume":"8","author":"S Barquera","year":"2020","unstructured":"Barquera S, Rivera JA. Obesity in mexico: rapid epidemiological transition and food industry interference in health policies. Lancet Diabetes Endocrinol. 2020;8:746\u20137.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1002_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s40618-020-01267-9","volume":"44","author":"J P\u00e9rez-Galarza","year":"2021","unstructured":"P\u00e9rez-Galarza J, et al. Prevalence of overweight and metabolic syndrome, and associated sociodemographic factors among adult Ecuadorian populations: the ENSANUT-ECU study. J Endocrinol Invest. 2021;44:63\u201374.","journal-title":"J Endocrinol Invest"},{"key":"1002_CR30","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1186\/s12913-022-08417-0","volume":"22","author":"R Garcia-Diaz","year":"2022","unstructured":"Garcia-Diaz R. Effective access to health care in Mexico. BMC Health Serv Res. 2022;22:1027.","journal-title":"BMC Health Serv Res"},{"key":"1002_CR31","unstructured":"The relationship between timing of onset of menarche and depressive symptoms from adolescence to adulthood | Epidemiology and Psychiatric Sciences | Cambridge Core. https:\/\/www.cambridge.org\/core\/journals\/epidemiology-and-psychiatric-sciences\/article\/relationship-between-timing-of-onset-of-menarche-and-depressive-symptoms-from-adolescence-to-adulthood\/CB8FACEF30298A63F2FC74E01F986A73"},{"key":"1002_CR32","unstructured":"Lifestyle changes in women with polycystic ovary syndrome - Moran, LJ\u2013\u20092011 | Cochrane Library. https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007506.pub2\/full"},{"key":"1002_CR33","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","volume":"384","author":"M Ng","year":"2014","unstructured":"Ng M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384:766\u201381.","journal-title":"Lancet"},{"key":"1002_CR34","doi-asserted-by":"publisher","unstructured":"Updated adolescent diagnostic criteria for polycystic ovary syndrome: impact on prevalence and longitudinal body mass index trajectories from birth to adulthood | BMC Medicine | Full Text. https:\/\/bmcmedicine.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12916-020-01861-x","DOI":"10.1186\/s12916-020-01861-x"},{"key":"1002_CR35","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/humupd\/dmt061","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly D, et al. Definition and significance of polycystic ovarian morphology: a task force report from the androgen excess and polycystic ovary syndrome society. Hum Reprod Update. 2014;20:334\u201352.","journal-title":"Hum Reprod Update"},{"key":"1002_CR36","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.dsx.2021.03.031","volume":"15","author":"Endocrine disrupting chemical","year":"2021","unstructured":"Endocrine disrupting chemical. Bisphenol A and its potential effects on female health. Diabetes Metabolic Syndrome: Clin Res Reviews. 2021;15:803\u201311.","journal-title":"Diabetes Metabolic Syndrome: Clin Res Reviews"},{"key":"1002_CR37","doi-asserted-by":"publisher","first-page":"100361","DOI":"10.1016\/j.gfs.2020.100361","volume":"25","author":"processed Urbanization","year":"2020","unstructured":"Urbanization processed foods, and eating out in India. Global Food Secur. 2020;25:100361.","journal-title":"Global Food Secur"},{"key":"1002_CR38","doi-asserted-by":"crossref","unstructured":"Lim SS, Hutchison SK, Ryswyk EV, Norman RJ, Teede HJ, Moran LJ. Lifestyle changes in women with polycystic ovary syndrome - Lim, SS - 2019 | Cochrane Library. [cited 2024 Aug 27]; Available from: https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007506.pub4\/full","DOI":"10.1002\/14651858.CD007506.pub4"},{"key":"1002_CR39","unstructured":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome\u2020\u2021 | Human Reproduction | Oxford Academic. https:\/\/academic.oup.com\/humrep\/article\/33\/9\/1602\/5056069"},{"key":"1002_CR40","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1210\/er.2007-0012","volume":"28","author":"DM Lonard","year":"2007","unstructured":"Lonard DM, Lanz RB, O\u2019Malley BW. Nuclear receptor coregulators and human disease. Endocr Rev. 2007;28:575\u201387.","journal-title":"Endocr Rev"}],"container-title":["Journal of Health, Population and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-025-01002-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41043-025-01002-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-025-01002-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:17:37Z","timestamp":1752139057000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhpn.biomedcentral.com\/articles\/10.1186\/s41043-025-01002-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1002"],"URL":"https:\/\/doi.org\/10.1186\/s41043-025-01002-1","relation":{},"ISSN":["2072-1315"],"issn-type":[{"value":"2072-1315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}